These cytokines contribute to pro-cancer inflammation, which is known to aggravate cancer progression, and activate several pathways, such as epithelial-mesenchymal transition (EMT), Notch1 signaling, and angiogenesis8–11. Here, NOTCH1 is linked to cancer.